# Naproxen Sodium

NDC: 63868-465
Generic name: NAPROXEN SODIUM
Labeler / Manufacturer: Chain Drug Marketing Association
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, COATED
Routes: ORAL
Marketing started: 20090903
Marketing ended: 20271231
FDA application: ANDA079096

## Active ingredients

- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63868-465"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63868-465
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d9e72c3f-addc-4391-a7a4-2680a3e7f5c4